Welcome


      “The 6th International CTA Symposium in Tucson, AZ in January, 2006 brought together many leaders in Transplant and Reconstructive Microsurgery. Join us for another exciting conference that brings together leaders in transplant, immunosuppression and tolerance for a look at CTA today and in the future.”

--Warren C. Breidenbach, MD    
Chair    

General Information

Meeting Objectives:

  1. Discuss the immunologic risks associated with Composite Tissue Allotransplantation.
  2. Review the role of T regulatory cells in allograft rejection and CTA.
  3. Discuss progress in CTA around the world.

Target Audience:

  1. Reconstructive microsurgeons
  2. Hand surgeons
  3. Immunologists
  4. Transplant surgeons
  5. Academic as well as private practice clinicians and researchers

 

 

The Composite Tissue Allotransplantation session has been approved for 4.0 hours Category 1 CME credit.

Jewish Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Jewish Hospital takes responsibility for the content, quality and scientific interest of this CME activity. Jewish Hospital designates this continuing education activity for a maximum of 4.0 credit hours in category I toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity.

 

Presented By